APA (7th ed.) Citation

Pennell, D., Porter, J., Cappellini, M., Chan, L., El-Beshlawy, A., Aydinok, Y., . . . Taher, A. (2010). Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone therapy. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Pennell, D., et al. Deferasirox Effectively Removes Cardiac Iron in Beta-thalassaemia Patients with Myocardial Siderosis Previously Chelated with Deferoxamine Monotherapy or Deferoxamine-deferiprone Therapy. Ferrata Storti Foundation, 2010.

MLA (9th ed.) Citation

Pennell, D., et al. Deferasirox Effectively Removes Cardiac Iron in Beta-thalassaemia Patients with Myocardial Siderosis Previously Chelated with Deferoxamine Monotherapy or Deferoxamine-deferiprone Therapy. Ferrata Storti Foundation, 2010.